FROVATRIPTAN SUCCINATE - Food and Drug Administration

Manufacturer: Food and Drug Administration
Effective date: 2026-01-28
Label type: Indexing - Product Concept
Version: 5
Source: full-release
Hydrated at: 2026-06-05 00:26:51

Label at a glance#

ProductFROVATRIPTAN SUCCINATE

Active ingredientFROVATRIPTAN SUCCINATE

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 2 matching rows.

FROVATRIPTAN SUCCINATE
FROVATRIPTAN

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 1 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
FROVATRIPTAN SUCCINATE	D28J6W18HY	ACTIM

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
FROVATRIPTAN SUCCINATE	FROVATRIPTAN SUCCINATE	Leading Pharma, LLC	d303af88-e0c1-4fb2-ba8e-83b7e6d163cd	2026-06-27	Warnings, Adverse reactions	Name fallback brand name: FROVATRIPTAN SUCCINATE generic name: FROVATRIPTAN SUCCINATE
frovatriptan succinate	FROVATRIPTAN SUCCINATE	Glenmark Pharmaceuticals Inc., USA	03a58215-dba7-4f63-8b98-d74d054a574a	2026-01-28	Warnings, Adverse reactions	Name fallback brand name: frovatriptan succinate generic name: FROVATRIPTAN SUCCINATE
FROVATRIPTAN	FROVATRIPTAN SUCCINATE	Ingenus Pharmaceuticals, LLC	92c91060-c06e-4a8a-b586-a3fb25c33433	2025-11-26	Warnings, Adverse reactions	Name fallback generic name: FROVATRIPTAN SUCCINATE
Frovatriptan	FROVATRIPTAN SUCCINATE	Amneal Pharmaceuticals NY LLC	94b996dc-ddc4-41ce-9a9f-3d91cb187473	2019-09-30	Warnings, Adverse reactions	Name fallback generic name: FROVATRIPTAN SUCCINATE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.